Log in

SANJIVIN Sanjivani Paranteral Ltd. BSE · India

Sanjivani Paranteral (SANJIVIN) news

Sanjivani Paranteral Ltd. is a public biotech or pharmaceutical company listed on BSE under the ticker SANJIVIN, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Sanjivani Paranteral news

We have not published a story on Sanjivani Paranteral yet. When there is news, it will appear here.

Questions about Sanjivani Paranteral

What is the ticker symbol of Sanjivani Paranteral?

Sanjivani Paranteral Ltd. trades under the ticker SANJIVIN on BSE.

Where is Sanjivani Paranteral listed?

Sanjivani Paranteral Ltd. is listed on BSE.

Which country or territory is Sanjivani Paranteral listed under?

Our directory records Sanjivani Paranteral Ltd. under India.

What does Sanjivani Paranteral do?

Our directory classifies Sanjivani Paranteral Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Sanjivani Paranteral?

The ISIN recorded for Sanjivani Paranteral Ltd. is INE860D01013.

Does aibio.space cover Sanjivani Paranteral?

aibio.space lists Sanjivani Paranteral Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Sanjivani Paranteral?

Companies in our directory listed in the same country and business area as Sanjivani Paranteral: Sunrest Lifescience, Brawn Biotech, Venus Remedies, Accent Microcell, Trinity League India, Lasa Supergenerics.

Investor discussion: Sanjivani Paranteral

Members talk about Sanjivani Paranteral (SANJIVIN). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BSE:SANJIVIN on TradingView.

Listing details

Sanjivani Paranteral Ltd. is a public biotech or pharmaceutical company listed on BSE under the ticker SANJIVIN, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Sanjivani Paranteral Ltd.
Ticker
SANJIVIN
Listing
BSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE860D01013
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.